Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UroGen’s Mitomycin: Are Randomized Trials For Bladder Cancer Necessary?
May 19 2025
•
By
Sue Sutter
Is a randomized trial a better fit for some bladder cancers?
(Shutterstock)
More from US Advisory Committees
More from Pathways & Standards